Regulatory Actions

FDA investigates improper disposal of bioengineered pigs

Published in Medical Letter on the CDC and FDA, March 2nd, 2003

The U.S. Food and Drug Administration (FDA) has determined that pigs involved in certain bioengineering studies at the University of Illinois-Urbana/Champaign were possibly not properly disposed of, and may have entered the food supply.

The agency believes that, based on present information, this incident poses no public health risk. Nevertheless, if confirmed, it would represent a significant breach of the FDA requirements for this study - warranting strong action against the responsible parties.

To date, this appears to be an isolated incident in which measures already in place to dispose of experimental transgenic animals may not have been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-03-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry